Literature DB >> 22475101

Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6.

A Bolognesi1, L Polito, V Scicchitano, C Orrico, G Pasquinelli, S Musiani, S Santi, M Riccio, M Bortolotti, M G Battelli.   

Abstract

Saporin-S6 is a single-chain ribosome-inactivating protein (RIP) that has low toxicity in cells and animals. When the protein is bound to a carrier that facilitates cellular uptake, the protein becomes highly and selectively toxic to the cellular target of the carrier. Thus, saporin-S6 is one of the most widely used RIPs in the preparation of immunoconjugates for anti-cancer therapy. The endocytosis of saporin-S6 by the neoplastic HeLa cells and the subsequent intracellular trafficking were investigated by confocal microscopy that utilises indirect immunofluorescence analysis and transmission electron microscopy that utilises a direct assay with gold-conjugated saporin-S6 and an indirect immunoelectron microscopy assay. Our results indicate that saporin-S6 was taken up by cells mainly through receptor-independent endocytosis. Confocal microscopy analysis showed around 30% co-localisation of saporin-S6 with the endosomal compartment and less than 10% co-localisation with the Golgi apparatus. The pathway identified by the immunofluorescence assay and transmission electron microscopy displayed a progressive accumulation of saporin-S6 in perinuclear vesicular structures. The main findings of this work are the following: i) the nuclear localisation of saporin-S6 and ii) the presence of DNA gaps resulting from abasic sites in HeLa nuclei after intoxication with saporin-S6.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22475101

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  16 in total

1.  Biological activities of the antiviral protein BE27 from sugar beet (Beta vulgaris L.).

Authors:  Rosario Iglesias; Lucía Citores; Antimo Di Maro; José M Ferreras
Journal:  Planta       Date:  2014-10-19       Impact factor: 4.116

2.  Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice.

Authors:  Chunyan Gao; Jocelyn A Schroeder; Feng Xue; Weiqing Jing; Yuanhua Cai; Amelia Scheck; Saravanan Subramaniam; Sridhar Rao; Hartmut Weiler; Agnieszka Czechowicz; Qizhen Shi
Journal:  Blood Adv       Date:  2019-09-24

3.  Insights into the mechanism of cell death induced by saporin delivered into cancer cells by an antibody fusion protein targeting the transferrin receptor 1.

Authors:  Tracy R Daniels-Wells; Gustavo Helguera; José A Rodríguez; Lai Sum Leoh; Michael A Erb; Graciel Diamante; David Casero; Matteo Pellegrini; Otoniel Martínez-Maza; Manuel L Penichet
Journal:  Toxicol In Vitro       Date:  2012-10-17       Impact factor: 3.500

4.  Reporter assay for endo/lysosomal escape of toxin-based therapeutics.

Authors:  Roger Gilabert-Oriol; Mayank Thakur; Benedicta von Mallinckrodt; Cheenu Bhargava; Burkhard Wiesner; Jenny Eichhorst; Matthias F Melzig; Hendrik Fuchs; Alexander Weng
Journal:  Toxins (Basel)       Date:  2014-05-22       Impact factor: 4.546

Review 5.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

6.  Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells.

Authors:  Letizia Polito; Daniele Mercatelli; Massimo Bortolotti; Stefania Maiello; Alice Djemil; Maria Giulia Battelli; Andrea Bolognesi
Journal:  Toxins (Basel)       Date:  2017-05-30       Impact factor: 4.546

7.  Efficacy of photochemical internalisation using disulfonated chlorin and porphyrin photosensitisers: An in vitro study in 2D and 3D prostate cancer models.

Authors:  Alejandra Martinez de Pinillos Bayona; Josephine H Woodhams; Hayley Pye; Rifat A Hamoudi; Caroline M Moore; Alexander J MacRobert
Journal:  Cancer Lett       Date:  2017-02-20       Impact factor: 8.679

Review 8.  Strategies to Improve the Clinical Utility of Saporin-Based Targeted Toxins.

Authors:  Francesco Giansanti; David J Flavell; Francesco Angelucci; Maria Serena Fabbrini; Rodolfo Ippoliti
Journal:  Toxins (Basel)       Date:  2018-02-13       Impact factor: 4.546

Review 9.  Saporin-S6: a useful tool in cancer therapy.

Authors:  Letizia Polito; Massimo Bortolotti; Daniele Mercatelli; Maria Giulia Battelli; Andrea Bolognesi
Journal:  Toxins (Basel)       Date:  2013-10-07       Impact factor: 4.546

10.  High in Vitro Anti-Tumor Efficacy of Dimeric Rituximab/Saporin-S6 Immunotoxin.

Authors:  Massimo Bortolotti; Andrea Bolognesi; Maria Giulia Battelli; Letizia Polito
Journal:  Toxins (Basel)       Date:  2016-06-21       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.